Abstract
Asymmetric synthesis of α-quaternary chiral lactam derivatives as novel anticancer agents and evaluation of their cytotoxic potentials and spectrums are reported. Among the developed lactam derivatives, the most active new compounds (S)-4m and (S)-4n synthesized via asymmetric phase-transfer catalytic alkylation in very high optical yields (98 % ee) show promising in vitro anticancer activities with low micromolar IC50 values against colon, uterus, lung, and breast human cancer cells.
| Original language | English |
|---|---|
| Pages (from-to) | 1264-1270 |
| Number of pages | 7 |
| Journal | Archives of Pharmacal Research |
| Volume | 37 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Oct 2014 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anticancer activity
- Breast cancers
- Colon
- Lung
- Phase-transfer catalytic alkylation
- α-Quaternary chiral lactam
Fingerprint
Dive into the research topics of 'Asymmetric synthesis and evaluation of α-quaternary chiral lactam derivatives as novel anticancer agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver